ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 51 - 60 of 60
Presenter(s): Kate Hutcheson, PhD, CCC-SLP, BSC-S; Katherine Connelly MA, CCC-SLP
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This session—a recorded session from ASHA’s 2020 Health Care Connect online conference—discusses cancer basics, treatment options, and their functional impacts as they relate to swallowing and cognitive-communication. The speakers discuss common referrals in acute care oncology settings and describe an algorithm for clinical decision-making.
Presenter(s): Jessica L Fanning, PhD, CCC-SLP ; Daphne Sage Martell, MA, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The session describes a case study that investigated the effectiveness of using a Comprehensive Integrated Approach to treat stuttering with a bilingual-bicultural Spanish-English adult who experienced stuttering. The case study queried whether a monolingual English-speaking clinician could effectively guide a bilingual-bicultural Spanish-English speaking adult who stuttered to transfer skills to a second language. The intervention addressed the client's bilingual-bicultural performance on measures of speech fluency, strategy use, reactions to stuttering, problem-solving, and quality of life.
Presenter(s): Mary R. T. Kennedy, PhD, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session explores the challenges that college students face after brain injury. The speaker discusses a coaching approach that is “least restrictive” yet supports and instructs students in self-regulation. The speaker also shares practical, metacognitive strategies and tools that support students’ executive functions so they can meet academic and social goals. This course is a recorded session from the 2020 online conference “Maximizing Functional Outcomes for Individuals With Traumatic Brain Injuries.”
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
Presenter(s): Nicole Cruse, PhD; Nicholas Behn; Victor Piotto; Carl A Coelho, PhD, BC-ANCDS
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session discusses a study that examined the feasibility of telehealth administration of narrative and procedural discourse tasks to individuals with TBI and matched controls. Results support the feasibility of collecting discourse samples via telehealth. Although the participants' discourse performance distinguished the TBI and control groups on the narrative task, no differences between the groups were noted for the procedural task.
Presenter(s): Shriya Basu, PhD, CCC-SLP; Lei Sun, PhD, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session shares findings of an exploratory survey study exploring the impact of the COVID-19 pandemic on communication, mental health, and quality of life (QoL) in people who stutter. The course discusses how the pandemic affects people with communication disorders, then shifts to discussing mental health, communication, and QoL in people who stutter and how the COVID-19 pandemic amplifies existing challenges.
Presenter(s): Sarah A Cust, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This presentation addresses the underlying neuropathology of ataxia, dysarthria-specific assessment and treatment for degenerative ataxias, and the importance of cognitive assessment and treatment. The presenter highlights recent advances in intervention, including noninvasive brain stimulation.
Presenter(s): Bethany L Kusek , MA, CCC-SLP; Andrea Elise Kremeier, MS, CCC-SLP, CBIS; Jett Mickelsen Stenson, MS, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: In the era of COVID-19, clinicians in health care settings have faced challenges in the evaluation and treatment of a new patient population - those who have had COVID-19 - requiring us to reframe our current treatment techniques. This session focuses on reinventing the speech-language pathologist's approach to treatment of respiratory activity tolerance for motor speech. It addresses collaboration with physical and occupational therapists for incorporation of dual motor tasks with more traditional treatment. Speakers discuss goal writing and tips for tracking measurable outcomes.
Presenter(s): Cindy Washington; Robin Baack; Sabiha Parveen, PhD, CCC-SLP; Abby Welke
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Approximately 1 million people are currently living with Parkinson's disease (PD) in the United States, with more than 60,000 people newly diagnosed with PD each year. Although PD can often be effectively managed by a combination of pharmacological and nonpharmacological options during the earlier stages, many individuals with PD experience progressive disability and require increased support from health and social services. This course describes a study that includes findings from semi-structured interviews with people with PD and their family members (based in Oklahoma, Texas, and Arkansas) about their current unmet needs and barriers to service delivery. In addition, the course discusses some of the future directions and avenues that may benefit the PD community.
Course cover image
Presenter(s): Jeanne Gallée; Jade Cartwright; Anna Volkmer; Anne Whitworth; Deborah Hersh
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This on demand webinar features a discussion among five authors of the American Journal of Speech-Language Pathology article "'Please Don't Assess Him to Destruction': The R.A.I.S.E. Assessment Framework for Primary Progressive Aphasia." The authors discussed the R.A.I.S.E. assessment framework and its clinical applications and future directions.
<< 1 2 3 4 5 6 > >>